Nah not kidding. Have they got the funds/loan from Prospere yet? They may well decide to pull the pin if not based on share price performance and risk associated with it's freefall
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025